Boris Seletsky

Boris Seletsky is a highly experienced medical and synthetic organic chemist with 26.8 years of work experience. He has expertise in medicinal chemistry, drug discovery, organic synthesis, and chemistry. Boris has worked as a senior scientist at Celgene and Quantum Technology Group, where he contributed to the discovery of cancer therapy approved in 70 countries for breast cancer treatment. He is skilled in total synthesis of natural products, solution, and solid-phase synthesis of macrocyclic and heterocyclic compounds. Boris is a detail-oriented and detail-oriented team member who consistently delivers high-quality results. He is a quick learner and adapts to diverse work environments.